Welcome to our dedicated page for Fosun Internatio news (Ticker: FOSUY), a resource for investors and traders seeking the latest updates and insights on Fosun Internatio stock.
News about Fosun International Limited (FOSUY) covers a broad range of topics reflecting its activities as a global innovation-driven consumer group. Company announcements and media releases describe developments across pharmaceuticals and healthcare, cultural tourism and consumption, financial services, and insurance, as well as updates on its innovation and globalization strategy.
Investors and observers can find news on Fosun’s pharmaceutical and healthcare initiatives, including progress in innovative drugs, medical devices, and healthcare services under entities such as Fosun Pharma and Henlius. Releases highlight clinical and regulatory milestones, new therapeutic indications, and the use of artificial intelligence in areas such as drug development decision-making and clinical trial prediction.
Coverage also includes cultural tourism and consumption news, such as performance and expansion of Club Med resorts under Fosun Tourism Group, cultural events, and consumer-focused projects. In financial services and insurance, news items discuss developments at Fosun Insurance Portugal (Fidelidade), asset servicing activities in Europe, and strategic portfolio adjustments, including asset sales and retained businesses.
Another important theme in Fosun-related news is ESG and sustainability. Articles describe its ESG ratings, inclusion in sustainability indices and yearbooks, climate disclosure practices, and social responsibility programs such as the Rural Doctors Program and contributions to global malaria treatment. Governance and award recognitions, including honors from organizations like Corporate Governance Asia, also feature prominently.
For those following FOSUY, this news stream provides insight into how Fosun advances its stated strategy of "Innovation + Globalization", how its core subsidiaries perform, and how it integrates ESG considerations into its operations. Regularly reviewing these updates can help readers understand the group’s evolving business focus and corporate priorities.
Fosun International reported a revenue of RMB 175.39 billion for 2022, an 8.7% increase despite challenges from the pandemic and international market volatility, with a net profit of RMB 0.54 billion. The company emphasized recovery in 2023, particularly in tourism and commercial sectors, and expressed confidence in future growth. Fosun divested non-core assets to streamline operations and focused on core business strengths. Notably, it received an MSCI ESG rating of AA and maintained stable debt ratios. The company aims to enhance product competitiveness through innovation and global operations while continuing to prioritize ESG responsibilities.
Fosun International announced its 2022 annual results, highlighting a total revenue of RMB175.39 billion, up 8.7% year-on-year. Overseas revenue reached RMB77.4 billion, representing a 14% increase and making up 44% of total revenue. The company invested RMB10.4 billion in R&D, marking a 17% rise. However, net profit was RMB0.54 billion, a sharp decline from RMB10.08 billion in 2021 due to high business costs and market downturns. Fosun has focused on divesting non-core assets, generating cash inflows of nearly RMB30 billion to stabilize operations. As of January 2023, they secured a RMB12 billion syndicated loan.
On March 17-18, Guo Guangchang, Chairman of Fosun, participated in major economic forums in China, emphasizing innovation and global operations. In an interview, Guo highlighted Fosun's R&D investments, particularly in biopharmaceuticals, and expressed confidence in achieving set development goals for the year. The tourism sector shows significant recovery, with Atlantis Sanya's occupancy exceeding 90%. Fosun's diverse businesses demonstrated strong performance, with Yuyuan Garden attracting over 4 million visitors and Club Med achieving record business volumes. Guo called for maintaining corporate health and innovation as essential for sustainable growth.
The Yuyuan Garden Lantern Festival in Shanghai recently hosted consular officials from 51 countries, showcasing Chinese culture through vibrant lantern displays and traditional performances. Co-hosted by the Foreign Affairs Office of Shanghai, this year's festival featured themes from the classic 'The Classic of Mountains and Seas' and integrated digital technologies for an enhanced experience. Approximately 3 million visitors have attended, including a significant number from the younger generation. The event received international attention, with promotion from the Chinese Ministry of Foreign Affairs and participation in various events abroad, solidifying its status as a cultural highlight.
On February 4, 2023, at Molineux Stadium, Wolverhampton Wanderers celebrated the Lantern Festival with a vibrant event featuring traditional Rabbit Lanterns from the Yuyuan Garden Lantern Festival. The Wolves, who defeated Liverpool 3-0 in the Premier League, showcased cultural exchanges through festive displays and messages. Fosun, the owner of Wolves, aims to promote Chinese culture globally. The event attracted over 30,000 fans and marked the first introduction of the Chinese Lantern Festival to the Premier League, highlighting China's cultural heritage and enhancing Fosun's brand visibility.
On January 9, 2023, Fosun Foundation partnered with Fosun Pharma and Genuine Biotech to donate RMB100 million worth of Azvudine tablets aimed at combating COVID-19 in rural areas during the peak season following Chinese New Year. By January 29, 173,200 bottles were distributed across 116 counties in 19 regions, benefiting approximately 150,000 villagers, notably seniors over 65. The initiative faced challenges in logistics and timely distribution, but volunteer efforts facilitated the delivery process. Additionally, Fosun Foundation is enhancing the skills of rural doctors through specialized training and providing essential medical supplies and digital healthcare systems.
Fosun International reported significant growth during the Spring Festival Golden Week, attributed to recovering consumer confidence. The occupancy rates of Club Med resorts in China reached over 90%, with Atlantis Sanya hitting 97.4%. The Yuyuan Garden Lantern Festival attracted 2.33 million visitors, boosting consumption by 20% year-over-year. Fosun Health ensured a stable supply of COVID-19 treatment Azvudine during the holiday, with online sales up 244%. Analysts express optimism for Fosun's future, with expectations of strong growth in the family-oriented consumer sector as China's economy continues to recover.
Summary not available.
Summary not available.
Fosun Foundation has launched the second stage of its 'A Healthy Winter Action' initiative, delivering 19,600 bottles of Azvudine to rural clinics in 24 counties across China, including Sichuan, Chongqing, Gansu, Hainan, Yunnan, Guizhou, and Jiangxi. The program aims to support over 20,000 villagers, primarily seniors, amid the COVID-19 epidemic. Notably, a live-streamed training session on COVID-19 prevention attracted over 1.26 million viewers, including 15,783 rural doctors. This follows a previous donation of RMB 100 million worth of Azvudine to rural areas, highlighting the Foundation's commitment to improving healthcare access during the pandemic.